🔗 Share this article

An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Investigational Drug Acquiring Traction Online

The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are urged to contact these accounts directly for source information, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust market exists on messaging services, where communities with numerous of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers promote the drug there before redirecting buyers to other platforms for transactions.

Understanding Retatrutide

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could assist individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Experts Voice Concerns

Nevertheless, physicians and chemists have warned that the distribution of what is still an unlicensed drug in the UK is worrisome and could result in individuals injecting products of unknown origin.

Several experts stated the popularity for retatrutide could be connected to the rising price of licensed weight loss products such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still violate pharmaceutical, advertising, and customer regulations, potentially leading to fines, prosecution or imprisonment.

Service Response and Content Removal

Based on the social media company, the service has taken down problematic content and prohibited associated hashtags and search suggestions. The company stated it was dedicated to keeping the platform secure and allocating resources in strengthening compliance measures.

Digital Marketplace Activities

Investigations also found groups with up to 9,000 members selling the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up channels with thousands of users, populated with photos of weight loss, glowing reviews and step-by-step guides for preparing or administering at residence.

Within minutes of joining one group, a seller posted WhatsApp details, where the majority of purchases take place. The vendor sent an instruction manual and promised delivery within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about body mass, medical conditions or previous experience.

Product Details and Pricing

Inside these communities, posts show dark colored parcels with Royal Mail labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled pens typically sold at 160 pounds for 20mg. When asked how long a pen should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for Telegram said it regularly moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting materials they can’t verify. Although the science behind retatrutide is sound, these digital products may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in interest to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.

Her team has already seen individuals injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company experimental product not yet approved … may subject users to potentially serious medical dangers”.